China · Delayed Price · Currency is CNY Sino Biological,Inc. Statistics
Total Valuation
SHE:301047 has a market cap or net worth of CNY 9.35 billion. The enterprise value is 6.14 billion.
| Market Cap | 9.35B |
| Enterprise Value | 6.14B |
Important Dates
The next estimated earnings date is Tuesday, April 14, 2026.
| Earnings Date | Apr 14, 2026 |
| Ex-Dividend Date | Sep 22, 2025 |
Share Statistics
SHE:301047 has 121.64 million shares outstanding. The number of shares has decreased by -3.47% in one year.
| Current Share Class | 121.64M |
| Shares Outstanding | 121.64M |
| Shares Change (YoY) | -3.47% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 55.81% |
| Owned by Institutions (%) | 3.03% |
| Float | 41.17M |
Valuation Ratios
The trailing PE ratio is 71.49 and the forward PE ratio is 66.55.
| PE Ratio | 71.49 |
| Forward PE | 66.55 |
| PS Ratio | 14.16 |
| PB Ratio | 1.77 |
| P/TBV Ratio | 1.89 |
| P/FCF Ratio | 215.67 |
| P/OCF Ratio | 76.57 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 39.03, with an EV/FCF ratio of 141.62.
| EV / Earnings | 46.23 |
| EV / Sales | 9.30 |
| EV / EBITDA | 39.03 |
| EV / EBIT | 116.44 |
| EV / FCF | 141.62 |
Financial Position
The company has a current ratio of 27.84, with a Debt / Equity ratio of 0.01.
| Current Ratio | 27.84 |
| Quick Ratio | 27.01 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.33 |
| Debt / FCF | 1.20 |
| Interest Coverage | 15.62 |
Financial Efficiency
Return on equity (ROE) is 2.41% and return on invested capital (ROIC) is 2.29%.
| Return on Equity (ROE) | 2.41% |
| Return on Assets (ROA) | 0.57% |
| Return on Invested Capital (ROIC) | 2.29% |
| Return on Capital Employed (ROCE) | 0.99% |
| Revenue Per Employee | 646,588 |
| Profits Per Employee | 130,061 |
| Employee Count | 1,021 |
| Asset Turnover | 0.11 |
| Inventory Turnover | 2.60 |
Taxes
In the past 12 months, SHE:301047 has paid 15.02 million in taxes.
| Income Tax | 15.02M |
| Effective Tax Rate | 10.16% |
Stock Price Statistics
The stock price has increased by +28.70% in the last 52 weeks. The beta is 1.01, so SHE:301047's price volatility has been similar to the market average.
| Beta (5Y) | 1.01 |
| 52-Week Price Change | +28.70% |
| 50-Day Moving Average | 70.77 |
| 200-Day Moving Average | 69.78 |
| Relative Strength Index (RSI) | 62.03 |
| Average Volume (20 Days) | 1,642,799 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301047 had revenue of CNY 660.17 million and earned 132.79 million in profits. Earnings per share was 1.08.
| Revenue | 660.17M |
| Gross Profit | 474.89M |
| Operating Income | 52.72M |
| Pretax Income | 147.82M |
| Net Income | 132.79M |
| EBITDA | 131.77M |
| EBIT | 52.72M |
| Earnings Per Share (EPS) | 1.08 |
Balance Sheet
The company has 3.26 billion in cash and 52.05 million in debt, with a net cash position of 3.21 billion or 26.39 per share.
| Cash & Cash Equivalents | 3.26B |
| Total Debt | 52.05M |
| Net Cash | 3.21B |
| Net Cash Per Share | 26.39 |
| Equity (Book Value) | 5.28B |
| Book Value Per Share | 43.38 |
| Working Capital | 3.43B |
Cash Flow
In the last 12 months, operating cash flow was 122.10 million and capital expenditures -78.75 million, giving a free cash flow of 43.35 million.
| Operating Cash Flow | 122.10M |
| Capital Expenditures | -78.75M |
| Free Cash Flow | 43.35M |
| FCF Per Share | 0.36 |
Margins
Gross margin is 71.93%, with operating and profit margins of 7.99% and 20.11%.
| Gross Margin | 71.93% |
| Operating Margin | 7.99% |
| Pretax Margin | 22.39% |
| Profit Margin | 20.11% |
| EBITDA Margin | 19.96% |
| EBIT Margin | 7.99% |
| FCF Margin | 6.57% |
Dividends & Yields
This stock pays an annual dividend of 4.00, which amounts to a dividend yield of 5.15%.
| Dividend Per Share | 4.00 |
| Dividend Yield | 5.15% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 458.00% |
| Buyback Yield | 3.47% |
| Shareholder Yield | 8.71% |
| Earnings Yield | 1.42% |
| FCF Yield | 0.46% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 30, 2022. It was a forward split with a ratio of 1.9.
| Last Split Date | Mar 30, 2022 |
| Split Type | Forward |
| Split Ratio | 1.9 |
Scores
SHE:301047 has an Altman Z-Score of 25.5 and a Piotroski F-Score of 5.
| Altman Z-Score | 25.5 |
| Piotroski F-Score | 5 |